$WORX
SCWorx Corp. Stock $worx

$worx Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000121390022047878 Filed on August 15, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$986.9K	$992.4K	$1.031M
YoY Change	-13.28%	-9.44%	-10.35%
Cost Of Revenue	$693.4K	$623.6K	$697.6K
YoY Change	-3.97%	-15.24%	1.11%
Gross Profit	$293.6K	$368.9K	$333.3K
YoY Change	-29.44%	2.42%	-25.93%
Gross Profit Margin	29.75%	37.17%	32.33%
Selling, General & Admin	$832.7K	$932.2K	$1.099M
YoY Change	-39.57%	-41.94%	-8.38%
% of Gross Profit	283.62%	252.73%	329.86%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
% of Gross Profit	0.0%	0.0%	0.0%
Operating Expenses	$1.526M	$1.556M	$1.099M
YoY Change	10.75%	-33.55%	-9.14%
Operating Profit	-$539.1K	-$563.4K	-$766.1K
YoY Change	-43.95%	-54.77%	0.81%
Interest Expense		$32.76K
YoY Change
% of Operating Profit
Other Income/Expense, Net	$139.6K		$139.6K
YoY Change
Pretax Income	-$399.5K	-$563.4K	-$626.6K
YoY Change	-58.46%	-54.77%	-16.46%
Income Tax
% Of Pretax Income
Net Earnings	-$399.5K	-$563.4K	-$626.6K
YoY Change	-58.46%	-54.77%	-16.46%
Net Earnings / Revenue	-40.48%	-56.77%	-60.77%
Basic Earnings Per Share	-$0.03	-$0.05	-$0.06
Diluted Earnings Per Share	-$0.03	-$0.05	-$55.28K
COMMON SHARES
Basic Shares Outstanding	11.74M shares	11.44M shares	11.38M shares
Diluted Shares Outstanding	12.07M shares	11.44M shares	11.33M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$361.7K	$23.49K	$8.290K
YoY Change	-9.93%	-26.75%	-90.79%
Cash & Equivalents	$361.7K	$23.49K	$8.293K
Short-Term Investments
Other Short-Term Assets	$323.0K	$327.9K	$119.6K
YoY Change	243.87%	153.95%	-8.04%
Inventory		$44.50K	$156.6K
Prepaid Expenses
Receivables	$231.9K	$302.6K	$697.2K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$916.6K	$698.5K	$981.6K
YoY Change	-22.9%	-31.35%	-55.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Goodwill	$8.366M	$8.366M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$8.366M	$8.366M	$8.366M
YoY Change	-0.03%	-0.04%	-0.16%
TOTAL ASSETS
Total Short-Term Assets	$916.6K	$698.5K	$981.6K
Total Long-Term Assets	$8.366M	$8.366M	$8.366M
Total Assets	$9.283M	$9.065M	$9.348M
YoY Change	-2.87%	-3.44%	-11.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$600.0K	$600.0K	$1.854M
YoY Change	-75.96%	-76.51%	-0.88%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.329M	$2.625M	$2.843M
YoY Change	-29.78%	-27.09%	-35.97%
LONG-TERM LIABILITIES
Long-Term Debt	$154.4K	$294.0K	$294.0K
YoY Change	-64.39%	-32.2%	-31.63%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$154.4K	$294.0K	$294.0K
YoY Change	-64.39%	-32.2%	-31.63%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.329M	$2.625M	$2.843M
Total Long-Term Liabilities	$154.4K	$294.0K	$294.0K
Total Liabilities	$2.484M	$2.919M	$3.137M
YoY Change	-33.79%	-27.63%	-35.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$25.60M	-$25.20M
YoY Change
Common Stock	$13.01K	$11.73K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.799M	$6.146M	$6.211M
YoY Change
Total Liabilities & Shareholders Equity	$9.283M	$9.065M	$9.348M
YoY Change	-2.87%	-3.44%	-11.89%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$399.5K	-$563.4K	-$626.6K
YoY Change	-58.46%	-54.77%	-16.46%
Depreciation, Depletion And Amortization	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Cash From Operating Activities	-$386.8K	$15.20K	-$62.78K
YoY Change	51.41%	-128.17%	-85.4%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change
Cash From Investing Activities	$0.00	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	725.1K	0.000
YoY Change	16.01%	-100.0%
NET CHANGE
Cash From Operating Activities	-386.8K	15.20K	-62.78K
Cash From Investing Activities	0.000	0.000
Cash From Financing Activities	725.1K	0.000
Net Change In Cash	338.2K	15.20K	$0.00
YoY Change	-8.47%	-127.97%
FREE CASH FLOW
Cash From Operating Activities	-$386.8K	$15.20K	-$62.78K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-37899
	dei	Entity Registrant Name EntityRegistrantName	SCWORX CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-5412331
	dei	Entity Address Address Line1 EntityAddressAddressLine1	590 Madison Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	21st Floor
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
	dei	City Area Code CityAreaCode	(844)
	dei	Local Phone Number LocalPhoneNumber	472-9679
	dei	Security12b Title Security12bTitle	Common stock, $0.001 par value per share
	dei	Trading Symbol TradingSymbol	WORX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	11737760	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23491	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	71075	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	302591	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	464851	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	44500	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	156600	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	327903	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	63942	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	698485	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	756468	usd
CY2022Q2	us-gaap	Goodwill Goodwill	8366467	usd
CY2021Q4	us-gaap	Goodwill Goodwill	8366467	usd
CY2022Q2	us-gaap	Assets Assets	9064952	usd
CY2021Q4	us-gaap	Assets Assets	9122935	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1657432	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1432710	usd
CY2022Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	153838	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	153838	usd
CY2022Q2	worx	Shareholder Advance ShareholderAdvance	100000	usd
CY2021Q4	worx	Shareholder Advance ShareholderAdvance	100000	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	589000	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	472750	usd
CY2022Q2	worx	Equity Financing Current EquityFinancingCurrent	125000	usd
CY2021Q4	worx	Equity Financing Current EquityFinancingCurrent	125000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2625270	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2284298	usd
CY2022Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	293972	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	433567	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	293972	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	433567	usd
CY2022Q2	us-gaap	Liabilities Liabilities	2919242	usd
CY2021Q4	us-gaap	Liabilities Liabilities	2717865	usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	40	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	40	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11726428	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11726428	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11293030	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11293030	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	11727	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	11293	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	30735143	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	29805028	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	600000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	600000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25201200	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24011291	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	6145710	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	6405070	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9064952	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9122935	usd
CY2022Q2	us-gaap	Revenues Revenues	992424	usd
CY2021Q2	us-gaap	Revenues Revenues	1095824	usd
	us-gaap	Revenues Revenues	2023373	usd
	us-gaap	Revenues Revenues	2244081	usd
CY2022Q2	worx	Cost Of Revenues CostOfRevenues	623548	usd
CY2021Q2	worx	Cost Of Revenues CostOfRevenues	735682	usd
	worx	Cost Of Revenues CostOfRevenues	1321184	usd
	worx	Cost Of Revenues CostOfRevenues	1430620	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	932239	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1605686	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2031693	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2806948	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	1555787	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	2341368	usd
	us-gaap	Operating Expenses OperatingExpenses	3352877	usd
	us-gaap	Operating Expenses OperatingExpenses	4237568	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-563363	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1245544	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1329504	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1993487	usd
	us-gaap	Gain Loss On Sales Of Consumer Loans GainLossOnSalesOfConsumerLoans	139595	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	139595	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-563363	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1245544	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1189909	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1993487	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-563363	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1245544	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1189909	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1993487	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.1
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.2
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11438071	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10140873	shares
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	139595	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11386773	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10070790	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	6211092	usd
CY2022Q2	worx	Stock Based Compensation StockBasedCompensation	200000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	297981	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-563363	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	6145710	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	6405070	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	85000	usd
	worx	Commitment Shares Issued In Conjunction With Capital Raise One CommitmentSharesIssuedInConjunctionWithCapitalRaiseOne	200000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	645549	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1189909	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	6145710	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	5736791	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	132557	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	729644	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1245544	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	5353448	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5734016	usd
	worx	Shares Issued For Vested Restricted Stock Units One SharesIssuedForVestedRestrictedStockUnitsOne	132557	usd
	worx	Shares Issued For Equity Financing SharesIssuedForEquityFinancing	250000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1230362	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1993487	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	5353448	usd
	us-gaap	Profit Loss ProfitLoss	-1189909	usd
	us-gaap	Profit Loss ProfitLoss	-1993487	usd
	us-gaap	Depreciation Depreciation	72548	usd
	worx	Change In Inventory Value ChangeInInventoryValue	112100	usd
	worx	Change In Inventory Value ChangeInInventoryValue	161440	usd
	worx	Gain Loss On Settlement Of Accounts Payable GainLossOnSettlementOfAccountsPayable	139595	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	645549	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1230362	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	78125	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	104501	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-84135	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-123451	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	63961	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	41491	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-475000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	309722	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-374774	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	116250	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-241500	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-47584	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-483950	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	139595	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-47584	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-344355	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	71075	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	376425	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23491	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32070	usd
	worx	Shares Issued For Equity Financings SharesIssuedForEquityFinancings	250000	usd
	worx	Commitment Shares Issued In Conjunction With Capital Raise CommitmentSharesIssuedInConjunctionWithCapitalRaise	200000	usd
	worx	Shares Issued For Vested Restricted Stock Units SharesIssuedForVestedRestrictedStockUnits	72	usd
	worx	Shares Issued For Vested Restricted Stock Units SharesIssuedForVestedRestrictedStockUnits	272	usd
CY2022Q2	worx	Acquired Technology Predecessor Cost AcquiredTechnologyPredecessorCost	0	usd
CY2022Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	250000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit and Other Risks</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash, accounts receivable and warrants. The Company believes that any concentration of credit risk in its accounts receivable is substantially mitigated by the Company’s evaluation process, relatively short collection terms and the high level of credit worthiness of its customers. The Company performs ongoing internal credit evaluations of its customers’ financial condition, obtains deposits and limits the amount of credit extended when deemed necessary but generally requires no collateral.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Significant customers are those which represent more than 10% of the Company’s revenue for each period presented, or the Company’s accounts receivable balance as of each respective balance sheet date. For each significant customer, revenue as a percentage of total revenue and accounts receivable as a percentage of total net accounts receivable are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="6" style="text-align: center; font-weight: bold">Revenue</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center"> </td> <td colspan="6" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="6" style="text-align: center; font-weight: bold">For the six months ended</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="6" style="text-align: center; font-weight: bold">Accounts Receivable</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">June 30,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">June 30,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left; font-weight: bold">Customers</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Customer A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">13</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">7</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">13</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Customer B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">40</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Customer D</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer E</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-137; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-138; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-139; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left">%</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p>
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.10	pure
CY2022Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	499861	usd
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	421736	usd
CY2022Q2	worx	Gowns In Inventory GownsInInventory	87000	usd
CY2021Q4	us-gaap	Other Inventory OtherInventory	366840	usd
CY2022Q2	us-gaap	Other Inventory OtherInventory	112100	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	523440	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	523440	usd
CY2022Q2	worx	Allowance For Obsolescence AllowanceForObsolescence	478940	usd
CY2021Q4	worx	Allowance For Obsolescence AllowanceForObsolescence	366840	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	44500	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	156600	usd
CY2021Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1865	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	72548	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	589000	usd
CY2021	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	472750	usd
CY2022Q2	worx	Contract Liabilities ContractLiabilities	589000	usd
CY2021Q4	worx	Contract Liabilities ContractLiabilities	472750	usd
CY2021Q2	worx	Operating Leases Cost OperatingLeasesCost	-6907	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and accompanying notes. The Company regularly evaluates estimates and assumptions related to the allowance for doubtful accounts, the estimated useful lives and recoverability of long-lived assets, stock-based compensation, goodwill, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Actual results could differ materially from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2020Q2	worx	Cares Act Description CARESActDescription	The CARES Act was established in order to enable small businesses to pay employees during the economic slowdown caused by COVID-19 by providing forgivable loans to qualifying businesses for up to 2.5 times their average monthly payroll costs. The amount borrowed under the CARES Act and used for payroll costs, rent, mortgage interest, and utility costs during the 24 week period after the date of loan disbursement is eligible to be forgiven provided that (a) the Company uses the PPP Funds during the eight week period after receipt thereof, and (b) the PPP Funds are only used to cover payroll costs (including benefits), rent, mortgage interest, and utility costs. While the full loan amount may be forgiven, the amount of loan forgiveness will be reduced if, among other reasons, the Company does not maintain staffing or payroll levels or less than 60% of the loan proceeds are used for payroll costs.
CY2020Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.01	pure
CY2020Q2	us-gaap	Debt Instrument Term DebtInstrumentTerm	P2Y
CY2021Q1	worx	Finance Leases Liability FinanceLeasesLiability	139595	usd
CY2021Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.01	pure
CY2021Q1	us-gaap	Debt Instrument Term DebtInstrumentTerm	P2Y
CY2022Q2	worx	Operating Lease Liabilities OperatingLeaseLiabilities	0	usd
CY2021Q4	worx	Operating Lease Liabilities OperatingLeaseLiabilities	0	usd
CY2022Q2	worx	Operating Leases Cost OperatingLeasesCost	434	usd
	worx	Share Based Compensation Common Stock ShareBasedCompensationCommonStock	1230362	usd
	worx	Operating Leases Cost OperatingLeasesCost	921	usd
	worx	Operating Leases Cost OperatingLeasesCost	13807	usd
CY2022Q2	worx	Total Leases Cost TotalLeasesCost	434	usd
CY2021Q2	worx	Total Leases Cost TotalLeasesCost	-6907	usd
	worx	Total Leases Cost TotalLeasesCost	921	usd
	worx	Total Leases Cost TotalLeasesCost	13807	usd
CY2022Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	434	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	921	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	100000	shares
CY2022Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	600000	usd
CY2022Q1	us-gaap	Retention Payable RetentionPayable	700000	usd
CY2022Q2	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	190000	usd
CY2022Q2	worx	Penalty Payment PenaltyPayment	125000	usd
CY2022Q2	us-gaap	Debt Instrument Periodic Payment Terms Balloon Payment To Be Paid DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid	471000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	32761.56	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	600000	usd
CY2022Q1	worx	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Restricted Units ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRestrictedUnits	71666	shares
CY2022Q2	worx	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Restricted Units ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRestrictedUnits	71666	shares
CY2022Q1	worx	Shares Issued As Settlement Of Accounts Payable1 SharesIssuedAsSettlementOfAccountsPayable1	12196	usd
CY2022Q1	worx	Accounts Payable Current1 AccountsPayableCurrent1	10000	usd
CY2022Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.82
CY2022Q1	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	75000	usd
CY2022Q1	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	75000	usd
CY2022Q2	us-gaap	Shares Issued SharesIssued	277778	shares
CY2022Q2	us-gaap	Equity Fair Value Adjustment EquityFairValueAdjustment	200000	usd
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.72
CY2020Q2	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	the Company received $515,000 of a committed $565,000 from the sale of 135,527 shares of common stock (at a price of $3.80 per share) and warrants to purchase 169,409 shares of common stock, at an exercise price of $4.00 per share. As of June 30, 2022, $415,000 worth of the shares and warrants have been issued.
CY2022Q2	worx	Equity Financing Current EquityFinancingCurrent	125000	usd
CY2022Q2	worx	Share Based Compensation Total ShareBasedCompensationTotal	297981	usd
CY2021Q2	worx	Share Based Compensation Total ShareBasedCompensationTotal	729644	usd
	worx	Share Based Compensation Total ShareBasedCompensationTotal	645549	usd
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	800000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	1000000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	297981	usd
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	729644	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	645549	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1230362	usd
CY2022Q2	worx	Share Based Compensation Common Stock ShareBasedCompensationCommonStock	297981	usd
CY2021Q2	worx	Share Based Compensation Common Stock ShareBasedCompensationCommonStock	729644	usd
	worx	Share Based Compensation Common Stock ShareBasedCompensationCommonStock	645549	usd
	worx	Share Based Compensation Total ShareBasedCompensationTotal	1230362	usd
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1161913	shares
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	881308	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1161913	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	881308	shares
CY2022Q2	us-gaap	Due From Officers Or Stockholders DueFromOfficersOrStockholders	153838	usd
CY2021Q4	us-gaap	Due From Officers Or Stockholders DueFromOfficersOrStockholders	153838	usd
CY2021Q3	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	100000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	11332	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2022Q2	worx	Shares Issued For Vested Restricted Stock Units One SharesIssuedForVestedRestrictedStockUnitsOne		usd
	worx	Shares Issued For Vested Restricted Stock Units One SharesIssuedForVestedRestrictedStockUnitsOne		usd
CY2021Q2	worx	Shares Issued For Vested Restricted Stock Units One SharesIssuedForVestedRestrictedStockUnitsOne		usd
CY2022Q2	worx	Conversion Of Series A Convertible Preferred Stock Into Common Stock ConversionOfSeriesAConvertiblePreferredStockIntoCommonStock		usd
	worx	Conversion Of Series A Convertible Preferred Stock Into Common Stock ConversionOfSeriesAConvertiblePreferredStockIntoCommonStock		usd
	us-gaap	Depreciation Depreciation		usd
	worx	Gain Loss On Settlement Of Accounts Payable GainLossOnSettlementOfAccountsPayable		usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
	us-gaap	Interest Paid InterestPaid		usd
	us-gaap	Interest Paid InterestPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	worx	Shares Issued For Equity Financings SharesIssuedForEquityFinancings		usd
	worx	Commitment Shares Issued In Conjunction With Capital Raise CommitmentSharesIssuedInConjunctionWithCapitalRaise		usd
CY2021Q2	us-gaap	Operating Lease Payments OperatingLeasePayments		usd
	us-gaap	Operating Lease Payments OperatingLeasePayments		usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent		pure
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent		pure
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent		pure
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent		pure
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001674227

Files In Submission

Name	View Source	Status
0001213900-22-047878-index-headers.html	Edgar Link	pending
0001213900-22-047878-index.html	Edgar Link	pending
0001213900-22-047878.txt	Edgar Link	pending
0001213900-22-047878-xbrl.zip	Edgar Link	pending
f10q0622ex31-1_scworxcorp.htm	Edgar Link	pending
f10q0622ex31-2_scworxcorp.htm	Edgar Link	pending
f10q0622ex32-1_scworxcorp.htm	Edgar Link	pending
f10q0622ex32-2_scworxcorp.htm	Edgar Link	pending
f10q0622_scworxcorp.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
f10q0622_scworxcorp_htm.xml	Edgar Link	completed
Show.js	Edgar Link	pending
worx-20220630.xsd	Edgar Link	pending
worx-20220630_pre.xml	Edgar Link	unprocessable
worx-20220630_lab.xml	Edgar Link	unprocessable
worx-20220630_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
worx-20220630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WORX
SCWorx Corp. Stock $worx

2022 Q3 Form 10-Q Financial Statement

#000121390022047878 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WORX SCWorx Corp. Stock $worx

2022 Q3 Form 10-Q Financial Statement

#000121390022047878 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WORX
SCWorx Corp. Stock $worx